Source link : https://newshealth.biz/health-news/remibrutinib-for-csu-shows-sustained-efficacy-at-1-year/
The medication is generally well tolerated in patients with chronic spontaneous urticaria whose symptoms do not respond adequately to H1 antihistamines. Medscape Medical News Source link : https://www.medscape.com/viewarticle/remibrutinib-csu-shows-sustained-efficacy-1-year-2025a1000w5w?src=rss Author : Publish date : 2025-11-19 01:04:00 Copyright for syndicated content belongs to the linked Source.
The post Remibrutinib for CSU Shows Sustained Efficacy at 1 Year first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-19 01:04:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8